BenevolentAI SA
AEX:BAI

Watchlist Manager
BenevolentAI SA Logo
BenevolentAI SA
AEX:BAI
Watchlist
Price: 0.081 EUR Market Closed
Market Cap: 11.6m EUR

EV/EBIT
Enterprise Value to EBIT

0.4
Current
-0.9
Median
16.7
Industry
Higher than median
Lower than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
0.4
=
Enterprise Value
-27.9m EUR
/
EBIT
-63.6m GBP
Market Cap EV/EBIT
UK
BenevolentAI SA
AEX:BAI
11.6m EUR 0.4
US
Eli Lilly and Co
NYSE:LLY
601.4B USD 28.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 17 702.3
US
Johnson & Johnson
NYSE:JNJ
418.1B USD 18.5
CH
Roche Holding AG
SIX:ROG
195.9B CHF 10.4
UK
AstraZeneca PLC
LSE:AZN
171.1B GBP 168.4
CH
Novartis AG
SIX:NOVN
185.9B CHF 13.4
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 10.5
US
Merck & Co Inc
NYSE:MRK
201.4B USD 9.5
IE
Endo International PLC
LSE:0Y5F
183.4B USD 731.8
US
Pfizer Inc
NYSE:PFE
139.7B USD 10.1
EBIT Growth EV/EBIT to Growth
UK
BenevolentAI SA
AEX:BAI
Average EV/EBIT: 1 700.3
0.4
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
28.2
33%
0.9
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
18.5
14%
1.3
CH
Roche Holding AG
SIX:ROG
10.4
6%
1.7
UK
AstraZeneca PLC
LSE:AZN
168.4
23%
7.3
CH
Novartis AG
SIX:NOVN
13.4
10%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
10.5
14%
0.8
US
Merck & Co Inc
NYSE:MRK
9.5
9%
1.1
IE
E
Endo International PLC
LSE:0Y5F
731.8
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.1
9%
1.1

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
0.4
2-Years Forward
EV/EBIT
0.9
3-Years Forward
EV/EBIT
1.4